Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 681

Similar articles for PubMed (Select 18769332)

1.

Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma.

Meyronet D, Massoma P, Thivolet F, Chalabreysse L, Rogemond V, Schlama A, Honnorat J, Thomasset N.

Am J Surg Pathol. 2008 Nov;32(11):1699-708. doi: 10.1097/PAS.0b013e31817dc37c.

PMID:
18769332
2.

Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?

Shia J, Tang LH, Weiser MR, Brenner B, Adsay NV, Stelow EB, Saltz LB, Qin J, Landmann R, Leonard GD, Dhall D, Temple L, Guillem JG, Paty PB, Kelsen D, Wong WD, Klimstra DS.

Am J Surg Pathol. 2008 May;32(5):719-31. doi: 10.1097/PAS.0b013e318159371c.

PMID:
18360283
3.

Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.

Jiang SX, Kameya T, Shoji M, Dobashi Y, Shinada J, Yoshimura H.

Am J Surg Pathol. 1998 May;22(5):526-37.

PMID:
9591721
4.

Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.

Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N, Bakker A, Guinee DG, Koss M, Travis WD.

Am J Pathol. 1996 May;148(5):1531-41.

5.

hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors.

Jiang SX, Kameya T, Asamura H, Umezawa A, Sato Y, Shinada J, Kawakubo Y, Igarashi T, Nagai K, Okayasu I.

Mod Pathol. 2004 Feb;17(2):222-9.

6.

Molecular markers help characterize neuroendocrine lung tumors.

Rusch VW, Klimstra DS, Venkatraman ES.

Ann Thorac Surg. 1996 Sep;62(3):798-809; discussion 809-10.

PMID:
8784011
7.

High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.

Sun L, Sakurai S, Sano T, Hironaka M, Kawashima O, Nakajima T.

Pathol Int. 2009 Aug;59(8):522-9. doi: 10.1111/j.1440-1827.2009.02402.x.

PMID:
19627535
8.
9.

Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.

Jiang SX, Kameya T, Sato Y, Yanase N, Yoshimura H, Kodama T.

Am J Pathol. 1996 Mar;148(3):837-46.

10.

[Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].

Li F, Zhong Z, Li R, Huang H, Wang L, Zheng D, Zhang D.

Zhongguo Fei Ai Za Zhi. 2010 Apr;13(4):317-21. doi: 10.3779/j.issn.1009-3419.2010.04.09. Chinese.

11.

Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung.

Papotti M, Croce S, Macrì L, Funaro A, Pecchioni C, Schindler M, Bussolati G.

Diagn Mol Pathol. 2000 Mar;9(1):47-57.

PMID:
10718213
12.

Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.

Pelosi G, Pasini F, Sonzogni A, Maffini F, Maisonneuve P, Iannucci A, Terzi A, De Manzoni G, Bresaola E, Viale G.

Cancer. 2003 May 15;97(10):2487-97.

13.

Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.

Battafarano RJ, Fernandez FG, Ritter J, Meyers BF, Guthrie TJ, Cooper JD, Patterson GA.

J Thorac Cardiovasc Surg. 2005 Jul;130(1):166-72.

PMID:
15999058
14.

Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung.

LaPoint RJ, Bourne PA, Wang HL, Xu H.

Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):401-6.

PMID:
18091382
15.

Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases.

Takei H, Asamura H, Maeshima A, Suzuki K, Kondo H, Niki T, Yamada T, Tsuchiya R, Matsuno Y.

J Thorac Cardiovasc Surg. 2002 Aug;124(2):285-92.

PMID:
12167788
16.

[Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma].

Zhao P, Hou N, Shao Y, Li XH.

Zhonghua Yi Xue Za Zhi. 2005 Jun 15;85(22):1526-9. Chinese.

PMID:
16179109
17.

High-grade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases.

Nassar H, Albores-Saavedra J, Klimstra DS.

Am J Surg Pathol. 2005 May;29(5):588-94.

PMID:
15832081
18.

Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas.

Akintola-Ogunremi O, Pfeifer JD, Tan BR, Yan Y, Zhu X, Hart J, Goldblum JR, Burgart L, Lauwers GY, Montgomery E, Lewin D, Washington K, Bronner M, Xiao SY, Greenson JK, Lamps L, Lazenby A, Wang HL.

Am J Surg Pathol. 2003 Dec;27(12):1551-8.

PMID:
14657715
19.

Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas.

Shida T, Furuya M, Nikaido T, Kishimoto T, Koda K, Oda K, Nakatani Y, Miyazaki M, Ishikura H.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):450-8.

20.

Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.

Liu Y, Sturgis CD, Grzybicki DM, Jasnosz KM, Olson PR, Tong M, Dabbs DD, Raab SS, Silverman JF.

Mod Pathol. 2001 Sep;14(9):880-5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk